As of November 7, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Viemed Healthcare, Inc. The largest reported stake is BlackRock Portfolio Management LLC's, at 6.4%. 5 filings are on record since July 1, 2025 (Schedule 13G, July 15, 2025).
Sell to companies like Viemed Healthcare, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Michael Moore · Percent: 5.9% · Shares: 2,294,018 · SCHEDULE 13D/A
- · Reporting person: Forager Capital Management, LLC · Sole voting: 1,886,872 · Shared voting: 0 · Sole dispositive: 1,886,872 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-24
- · Holder: Forager Capital Management, LLC · Percent: 7.2% · SCHEDULE 13G/A
- · Holder: BlackRock Portfolio Management LLC · Percent: 6.4% · SCHEDULE 13G
- · Holder: Forager Capital Management, LLC · Percent: 5.5% · SCHEDULE 13G
Viemed Healthcare, Inc. has 5 Schedule 13D or 13G filings on record since 2025-07-01. 2 holders' latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 6.4% | 2,540,114 | SCHEDULE 13G, 2025-07-15 | 2025-06-30 |
| 5.9% | 2,294,018 | SCHEDULE 13D/A, 2026-09-24 | 2026-09-24 | |
| Forager Capital Management, LLC | 4.9% | 1,886,872 | SCHEDULE 13G/A, 2026-07-24 | 2026-06-30 |
Holding shares or following this stake? See who's behind Viemed Healthcare, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Viemed Healthcare, Inc. and the records around it.
Viemed Healthcare, Inc. elsewhere on the record
Companies that share a holder
- Forager Capital Management, LLC also filed stake reports on 6 other companies: i3 Verticals, Inc. (Sep 2026), MasterCraft Boat Holdings, Inc. (Aug 2026), Oportun Financial Corporation (Jul 2026)
- BlackRock Portfolio Management LLC also filed stake reports on 118 other companies: AMERISAFE INC (Nov 2026), BlackRock ETF Trust (Nov 2026), iShares J.P. Morgan EM Local Currency Bond ETF (Nov 2026)
Watch Viemed Healthcare, Inc.
Get an email when Viemed Healthcare, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Viemed Healthcare, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Viemed Healthcare, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Viemed Healthcare, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Michael Moore | 708,206 | 1,585,812 | 708,206 | 1,585,812 | SCHEDULE 13D/A, 2026-09-24 |
| Moore Faster LLC | 0 | 1,585,812 | 0 | 1,585,812 | SCHEDULE 13D/A, 2026-09-24 |
| Forager Capital Management, LLC | 1,886,872 | 0 | 1,886,872 | 0 | SCHEDULE 13G/A, 2026-07-24 |
| Forager Fund, L.P. | 1,886,872 | 0 | 1,886,872 | 0 | SCHEDULE 13G/A, 2026-07-24 |
| Kissel Edward Urban | 0 | 1,886,872 | 0 | 1,886,872 | SCHEDULE 13G/A, 2026-07-24 |
| MacArthur Robert Symmes | 0 | 1,886,872 | 0 | 1,886,872 | SCHEDULE 13G/A, 2026-07-24 |
The latest filing identifies Viemed Healthcare, Inc. by CUSIP 92663R105 and gives its principal executive office as 625 E. Kaliste Saloom Rd., Lafayette, LA 70508 (SCHEDULE 13D/A, 2026-09-24).
What the percentages are based on
4.9%. The percentages of beneficial ownership reported herein, and on each Reporting Person's cover page to this Schedule 13G/A, are based on a total of 38,336,802 shares of Common Stock issued and outstanding as of April 29, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for its quarterly period ended March 31, 2026, filed with the Securities and Exchange Commission (the "SEC") on May 5, 2026.Forager Capital Management, LLC, SCHEDULE 13G/A, 2026-07-24
Purpose of Transaction (Item 4)
Michael Moore
Item 4 of the Schedule 13D is hereby amended and restated in its entirety as follows: Each of the Reporting Persons holds the Common Shares as reported herein for investment purposes and does not have any specific plans or proposals regarding the Issuer in such Reporting Person's capacity as a holder of Common Shares. Except as set forth below, each of the Reporting Persons does not have any current plans or proposals which relate to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D. On September 24, 2026, MF LLC entered into a trading plan with Morgan Stanley Smith Barney LLC (the "Trading Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Pursuant to the Trading Plan, Morgan Stanley Smith Barney LLC may sell up to 246,000 Common Shares of the Issuer held by MF LLC during the period beginning on the Selling Start Date, as determined under the Trading Plan, which will be no earlier than December 24, 2026, and ending November 30, 2027, subject to predetermined trading conditions established under the Trading Plan. The Trading Plan was adopted at a time when neither Moore nor MF LLC was aware of any material non-public information regarding the Issuer. A copy of the Trading Plan is filed as Exhibit 99.2 to this Amendment No. 3 and is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2026-09-24
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-01 | Forager Capital Management, LLC | 5.5% | SCHEDULE 13G |
| 2025-07-15 | BlackRock Portfolio Management LLC | 6.4% | SCHEDULE 13G |
| 2025-11-07 | Forager Capital Management, LLC | 7.2% | SCHEDULE 13G/A |
| 2026-07-24 | Forager Capital Management, LLC | 4.9% | SCHEDULE 13G/A |
| 2026-09-24 | Michael Moore | 5.9% | SCHEDULE 13D/A |
Questions about who owns Viemed Healthcare, Inc.
Who owns Viemed Healthcare, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Viemed Healthcare, Inc.: BlackRock Portfolio Management LLC (6.4%, Schedule 13G, filed 2025-07-15) and Michael Moore (5.9%, Schedule 13D/A, filed 2026-09-24).
Who are the largest shareholders of Viemed Healthcare, Inc.?
By the share each holder's latest filing reports, the largest holders of Viemed Healthcare, Inc. on this page are BlackRock Portfolio Management LLC (6.4%) and Michael Moore (5.9%).
When did BlackRock Portfolio Management LLC buy into Viemed Healthcare, Inc.?
The filings give report dates, not purchase dates. The earliest filing from BlackRock Portfolio Management LLC on this page is the Schedule 13G, filed 2025-07-15, reporting 6.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Viemed Healthcare, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.